Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells-Reference-Cited by-同舟云学术

Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells

Published:2011-02-18 Issue:6 Volume:46 Page:779-789
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Sugiyama Hiroaki,Onuki Kenichiro,Ishige Kazunori,Baba Nobue,Ueda Tetsuya,Matsuda Sachiko,Takeuchi Kaoru,Onodera Masafumi,Nakanuma Yasuni,Yamato Masayuki,Yamamoto Masakazu,Hyodo Ichinosuke,Shoda Junichi

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-011-0380-3.pdf

Reference34 articles.

1. Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology. 2008;48:308–21.

2. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet. 2005;366:1303–14.

3. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology. 2005;128:1655–67.

4. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507–17 (discussion 517–9).

5. Huang JL, Biehl TR, Lee FT, Zimmer PW, Ryan JA Jr. Outcomes after resection of cholangiocellular carcinoma. Am J Surg. 2004;187:612–7.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surufatinib combined with photodynamic therapy induces ferroptosis to inhibit cholangiocarcinoma in vitro and in tumor models;Frontiers in Pharmacology;2024-04-05

2. Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines;The American Journal of Pathology;2022-09

3. Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial;European Journal of Cancer;2022-02

4. Cholangiocarcinoma: new perspectives for new horizons;Expert Review of Gastroenterology & Hepatology;2021-11-09

5. Patient-Derived Organoids of Cholangiocarcinoma;International Journal of Molecular Sciences;2021-08-12